A citation-based method for searching scientific literature

Nancy C Andreasen, Marcus Pressler, Peg Nopoulos, Del Miller, Beng-Choon Ho. Biol Psychiatry 2010
Times Cited: 717







List of co-cited articles
551 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
44

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.
Richard S E Keefe, Terry E Goldberg, Philip D Harvey, James M Gold, Margaret P Poe, Leigh Coughenour. Schizophr Res 2004
906
11

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Oliver D Howes, Rob McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J M van Beveren, Michael L Birnbaum, Michael A P Bloomfield, Rodrigo A Bressan, Robert W Buchanan, William T Carpenter,[...]. Am J Psychiatry 2017
405
9

A rating scale for mania: reliability, validity and sensitivity.
R C Young, J T Biggs, V E Ziegler, D A Meyer. Br J Psychiatry 1978
9

Social cognition in schizophrenia.
Michael F Green, William P Horan, Junghee Lee. Nat Rev Neurosci 2015
488
8

International consensus study of antipsychotic dosing.
David M Gardner, Andrea L Murphy, Heather O'Donnell, Franca Centorrino, Ross J Baldessarini. Am J Psychiatry 2010
858
8

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
Marc De Hert, Johan Detraux, Ruud van Winkel, Weiping Yu, Christoph U Correll. Nat Rev Endocrinol 2011
607
7

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
N Tzourio-Mazoyer, B Landeau, D Papathanassiou, F Crivello, O Etard, N Delcroix, B Mazoyer, M Joliot. Neuroimage 2002
6

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
Keith H Nuechterlein, Michael F Green, Robert S Kern, Lyle E Baade, Deanna M Barch, Jonathan D Cohen, Susan Essock, Wayne S Fenton, Frederick J Frese, James M Gold,[...]. Am J Psychiatry 2008
6

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
Rahul S Desikan, Florent S├ęgonne, Bruce Fischl, Brian T Quinn, Bradford C Dickerson, Deborah Blacker, Randy L Buckner, Anders M Dale, R Paul Maguire, Bradley T Hyman,[...]. Neuroimage 2006
6


Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.
S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, O A Andreassen, C Arango, N Banaj, S Bouix,[...]. Mol Psychiatry 2018
325
5

Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.
Brett A Clementz, John A Sweeney, Jordan P Hamm, Elena I Ivleva, Lauren E Ethridge, Godfrey D Pearlson, Matcheri S Keshavan, Carol A Tamminga. Am J Psychiatry 2016
385
5

Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).
Carol A Tamminga, Elena I Ivleva, Matcheri S Keshavan, Godfrey D Pearlson, Brett A Clementz, Bradley Witte, David W Morris, Jeffrey Bishop, Gunvant K Thaker, John A Sweeney. Am J Psychiatry 2013
205
5


Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.
J Kaufman, B Birmaher, D Brent, U Rao, C Flynn, P Moreci, D Williamson, N Ryan. J Am Acad Child Adolesc Psychiatry 1997
5

Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.
Svetlana A Ivanova, Diana Z Osmanova, Maxim B Freidin, Olga Yu Fedorenko, Anastasia S Boiko, Ivan V Pozhidaev, Arkadiy V Semke, Nikolay A Bokhan, Alexey A Agarkov, Bob Wilffert,[...]. World J Biol Psychiatry 2017
18
27

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia.
S A Ivanova, A J M Loonen, P Pechlivanoglou, M B Freidin, A F Y Al Hadithy, E V Rudikov, I A Zhukova, N V Govorin, V A Sorokina, O Y Fedorenko,[...]. Transl Psychiatry 2012
40
12

The disconnection hypothesis.
K J Friston. Schizophr Res 1998
595
5

FreeSurfer.
Bruce Fischl. Neuroimage 2012
5


Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
Andreas Meyer-Lindenberg, Robert S Miletich, Philip D Kohn, Giuseppe Esposito, Richard E Carson, Mario Quarantelli, Daniel R Weinberger, Karen Faith Berman. Nat Neurosci 2002
473
4


Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis.
Toby Pillinger, Katherine Beck, Cristian Gobjila, Jacek G Donocik, Sameer Jauhar, Oliver D Howes. JAMA Psychiatry 2017
241
4

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.
Bruce Fischl, David H Salat, Evelina Busa, Marilyn Albert, Megan Dieterich, Christian Haselgrove, Andre van der Kouwe, Ron Killiany, David Kennedy, Shuna Klaveness,[...]. Neuron 2002
4

Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.
Alex J Mitchell, Davy Vancampfort, Kim Sweers, Ruud van Winkel, Weiping Yu, Marc De Hert. Schizophr Bull 2013
591
4

Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
Anthony C Ruocco, James L Reilly, Leah H Rubin, Alex R Daros, Elliot S Gershon, Carol A Tamminga, Godfrey D Pearlson, S Kristian Hill, Matcheri S Keshavan, Ruben C Gur,[...]. Schizophr Res 2014
55
7

Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
Arsime Demjaha, Robin M Murray, Philip K McGuire, Shitij Kapur, Oliver D Howes. Am J Psychiatry 2012
223
4

The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Oliver D Howes, Joseph Kambeitz, Euitae Kim, Daniel Stahl, Mark Slifstein, Anissa Abi-Dargham, Shitij Kapur. Arch Gen Psychiatry 2012
581
4

Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study.
Euitae Kim, Oliver D Howes, Mattia Veronese, Katherine Beck, Seongho Seo, Jin Woo Park, Jae Sung Lee, Yun-Sang Lee, Jun Soo Kwon. Neuropsychopharmacology 2017
64
6

Remission in schizophrenia: proposed criteria and rationale for consensus.
Nancy C Andreasen, William T Carpenter, John M Kane, Robert A Lasser, Stephen R Marder, Daniel R Weinberger. Am J Psychiatry 2005
4

Factor structure of the Barratt impulsiveness scale.
J H Patton, M S Stanford, E S Barratt. J Clin Psychol 1995
4

Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.
C F M G van Kesteren, H Gremmels, L D de Witte, E M Hol, A R Van Gool, P G Falkai, R S Kahn, I E C Sommer. Transl Psychiatry 2017
182
4

Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis.
Toby Pillinger, Robert A McCutcheon, Luke Vano, Yuya Mizuno, Atheeshaan Arumuham, Guy Hindley, Katherine Beck, Sridhar Natesan, Orestis Efthimiou, Andrea Cipriani,[...]. Lancet Psychiatry 2020
234
4

Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses.
David C Henderson, Brenda Vincenzi, Nicolas V Andrea, Melissa Ulloa, Paul M Copeland. Lancet Psychiatry 2015
144
4

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.
Davy Vancampfort, Brendon Stubbs, Alex J Mitchell, Marc De Hert, Martien Wampers, Philip B Ward, Simon Rosenbaum, Christoph U Correll. World Psychiatry 2015
592
4

The blood-brain barrier in psychosis.
Thomas A Pollak, Svetlana Drndarski, James M Stone, Anthony S David, Philip McGuire, N Joan Abbott. Lancet Psychiatry 2018
127
4


A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
4

Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
S Kristian Hill, James L Reilly, Richard S E Keefe, James M Gold, Jeffrey R Bishop, Elliot S Gershon, Carol A Tamminga, Godfrey D Pearlson, Matcheri S Keshavan, John A Sweeney. Am J Psychiatry 2013
230
4

Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications.
Brenda W J H Penninx, Sjors M M Lange. Dialogues Clin Neurosci 2018
75
5


The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
Mark R Wills, Emma Poole, Betty Lau, Ben Krishna, John H Sinclair. Cell Mol Immunol 2015
77
5


Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study.
Regine Barlinn, Susanne G Dudman, Lill Trogstad, Moustafa Gibory, Fredrik Muller, Per Magnus, Halvor Rollag. APMIS 2018
12
33

Pathogenesis of developmental anomalies of the central nervous system induced by congenital cytomegalovirus infection.
Hideya Kawasaki, Isao Kosugi, Shiori Meguro, Toshihide Iwashita. Pathol Int 2017
23
17

A comparison of FreeSurfer-generated data with and without manual intervention.
Christopher S McCarthy, Avinash Ramprashad, Carlie Thompson, Jo-Anna Botti, Ioana L Coman, Wendy R Kates. Front Neurosci 2015
83
4

Social cognition in schizophrenia: relationships with neurocognition and negative symptoms.
Mark J Sergi, Yuri Rassovsky, Clifford Widmark, Christopher Reist, Stephen Erhart, David L Braff, Stephen R Marder, Michael F Green. Schizophr Res 2007
255
4

Measuring movement disorders in antipsychotic drug trials: the need to define a new standard.
Anton J M Loonen, Herman M van Praag. J Clin Psychopharmacol 2007
30
10

The Schedule for the Assessment of Drug-Induced Movement Disorders (SADIMoD): test-retest reliability and concurrent validity.
Anton J. M. Loonen, Cees H. Doorschot, Dianne A. van Hemert, Marc C. J. M. Oostelbos, Arnold E. S. Sijben. Int J Neuropsychopharmacol 2000
25
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.